NCT00623402 Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00613509 Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma Status TERMINATED Phase PHASE2
NCT00610857 Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE2
NCT00610389 Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors Status UNKNOWN Phase PHASE2
NCT00601185 Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo. Status COMPLETED Phase N/A
NCT00600496 A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) Status COMPLETED Phase PHASE1
NCT00598507 Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00597272 Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma Status COMPLETED Phase NA
NCT00591370 Phase II Trial of Extended-Dosing Temozolomide in Patients With Melanoma Status COMPLETED Phase PHASE2
NCT00590824 Pilot hu14.18-IL2 in Resectable Recurrent Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE2
NCT00588341 Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection Status COMPLETED Phase PHASE2
NCT00588263 Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer Status WITHDRAWN Phase N/A
NCT00588198 Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma Status COMPLETED Phase N/A
NCT00587964 Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases Status COMPLETED Phase PHASE2
NCT00585000 A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma Status TERMINATED Phase PHASE1